NasdaqGS:TLRYPharmaceuticals
Tilray Brands (TLRY) Stock Revenue Growth Clashes With Persistent Losses
Tilray Brands entered this earnings release with the stock already under pressure and down 36% over the past three months. The immediate reaction is muted, with the share price slipping about 1% to US$3.99. That small move sits awkwardly beside a cannabis and consumer products group still posting losses and leaning on valuation appeal rather than profitability.
The main focus is scale versus earnings. Tilray Brands delivered roughly US$915.5m in full year revenue and US$61.1m in adjusted...